Targeted News Service

BridgeBio Pharma Prices $575 Million Convertible Notes Offering
March 05, 2025

BOSTON, Massachusetts, March 5 [Category: BizLaw/Legal] -- Goodwin, a law firm, issued the following news release:

* * *

BridgeBio Pharma Prices $575 Million Convertible Notes Offering

Goodwin's Life Sciences Capital Markets team advised BridgeBio Pharma, Inc. (Nasdaq: BBIO) on its offering of 1.75% Convertible Senior Notes due 2031. The offering priced at $500 million, plus the full exercise of the initial purchasers' option to purchase an additi . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form